lncRNAs and aging: a forgotten piece of DNA turns out to be key to preserving cells
Long non-coding RNAs, stretches of genetic material long assumed to do very little, turn out to play a crucial role in cellular aging. One of them, when replenished, can reduce lung tissue damage in mice.
Researchers have carried out a large-scale genetic experiment in which 32 long non-coding RNAs (lncRNAs) were systematically switched off in cells, after which the team measured what changed at the level of gene expression and chromatin. The study, published in Nature Aging, used a sophisticated combination of CRISPR technology and single-cell multiomics, a method that simultaneously maps gene expression and DNA structure in individual cells.
The focus was on lncRNAs linked to aging and senescence, the state in which cells stop dividing but do not die, instead secreting inflammatory signals that damage surrounding tissue. Senescence is one of the central mechanisms driving tissue aging and age-related disease. Switching off each of the 32 lncRNAs produced measurable changes in how other genes behaved, demonstrating that these molecules are not passive bystanders but active regulators of the aging process.
HOTAIRM1: from cancer research to aging biology
One lncRNA stood out: HOTAIRM1. It turned out to be connected to the regulation of DNA repair genes, a fundamental process that declines as cells grow older. When DNA damage accumulates and is not properly repaired, senescence accelerates. That HOTAIRM1 regulates this process had never previously been shown in the context of aging; until now, the gene had appeared mainly in cancer research.
The researchers went a step further: they replenished HOTAIRM1 in the lung tissue of mice and measured the effect on pulmonary fibrosis, the scarring of lung tissue that occurs with aging and in conditions such as idiopathic pulmonary fibrosis. The result was less fibrosis. This is early, mouse-based evidence, but it points toward a potentially new class of longevity intervention, one aimed not at proteins or small molecules but at non-coding RNAs that drive the molecular architecture of senescence.
Why this is more than a laboratory curiosity
The field of lncRNA research has wrestled with questions of relevance for years. Many lncRNAs are poorly conserved across species, difficult to target with existing drugs, and notoriously hard to study. But the availability of single-cell technology has made it possible to measure their effects with a precision that was previously out of reach. This study therefore also makes a methodological contribution: it shows how you can unravel lncRNA functions at scale in the context of aging. The next question is whether HOTAIRM1 and related molecules do the same thing in human tissue, and whether they will ever be approachable as therapeutic targets.